Skip to main content

Volume 14 - Issue 2 - February 2017

February 2017 Issue 2 Volume 14

Interview by Jennifer Ford
An interview with the principal investigator of the ongoing DRASTICO trial, which is comparing drug-eluting stent vs drug-eluting balloon in complex patients.
Case Report
Dhafer Salem, MD, MPH and Maja Delibasic, MD From Mercy Hospital Medical Center and Wayne State University, Henry Ford Health System, Emergency Medicine, Detroit, Michigan
The presented case demonstrates the success of angioplasty and stenting and the benefit of avoiding a decompression and revascularization surgery.
Editorial Commentary
Richard C. Kovach, MD From Deborah Heart and Lung Center, Browns Mills, New Jersey  
A commentary on a recently published article that explored the relationship between carotid stenting outcomes and operator experience.
Original Research
Lawrence A. Garcia, MD1; Michael Jaff, MD2; Krishna Rocha-Singh, MD3; Thomas Zeller, MD4; James McKinsey, MD5       From 1St. Elizabeth’s Medical Center, Brighton, Massachusetts; 2Massachusetts General Hospital, Boston, Massachusetts; 3Prairie Medical, Springfield, Illinois; 4Universitats-Herzzentrum Freiburg - Bad Krozingen, Bad Krozingen, Germany; and  5Mount Sinai University, New York, New York  
This study assesses the acute safety of directional atherectomy for endovascular treatment of peripheral arterial disease in infrainguinal arteries.
Editor's Corner
Craig Walker, MD Clinical Editor Interventional Cardiologist  Founder, President, and Medical Director Cardiovascular Institute of the South Clinical Professor of Medicine  Tulane University School of Medicine Louisiana State University School of Medicine
There is great debate about whether drug-eluting stent or drug-eluting balloon therapy should be utilized to treat symptomatic peripheral arterial disease.
Back to Top